Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
---|
05/23/1996 | WO1996015261A2 Nucleotide sequences hybridizing specifically with a genomic nucleic sequence of campylobacter |
05/23/1996 | WO1996015260A2 Nucleotide sequences specifically hybridising with a genomic nucleic sequence of campylobacter fetus |
05/23/1996 | WO1996015259A2 Assay for the measurement of multilineage stem cells and methods of use thereof |
05/23/1996 | WO1996015258A1 A scintillation proximity assay for n-acetylgalactosaminyltransferase activity |
05/23/1996 | WO1996015257A2 Steroid sulfatase assay |
05/23/1996 | WO1996015256A1 Enzymatic composition for clinical examination |
05/23/1996 | WO1996015255A2 Assay for proline iminopeptidase and other hydrolytic activities |
05/23/1996 | WO1996015254A1 Assay method for catheter related sepsis |
05/23/1996 | WO1996015249A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
05/23/1996 | WO1996015234A2 Lipid-splitting enzyme |
05/23/1996 | WO1996015233A1 Mutant dna encoding insulin-stimulated protein kinase |
05/23/1996 | WO1996015224A1 In vitro induction of dopaminergic cells |
05/23/1996 | WO1996015223A1 Biomaterial and method for obtaining it |
05/23/1996 | WO1996015222A1 HUMAN MutT2 |
05/23/1996 | WO1996015147A1 Human stanniocalcin-alpha |
05/23/1996 | WO1996015144A2 Chromosome 21 gene marker, compositions and methods using same |
05/23/1996 | WO1996015139A1 Quantitative method for early detection of mutant alleles and diagnostic kits for carrying out the method |
05/23/1996 | WO1996015122A1 Novel 1,2-dioxetane compounds with haloalkoxy groups, methods of preparation and use |
05/23/1996 | WO1996014934A1 Mesoscale sample preparation device and systems for determination and processing of analytes |
05/23/1996 | WO1996014933A1 Mesoscale devices for analysis of motile cells |
05/23/1996 | WO1996014877A1 Novel tumor suppressor gene, hic-1 |
05/23/1996 | WO1996014876A1 Yeast-based delivery vehicles |
05/23/1996 | WO1996014827A1 Sustained-release aromatic and method of detecting microorganism by using the same |
05/23/1996 | WO1996014737A1 Treating red blood cell solutions with anti-viral agents |
05/23/1996 | CA2594846A1 Novel 1,2-dioxetane compounds with haloalkoxy groups, methods of preparation and use |
05/23/1996 | CA2205414A1 Novel tumor suppressor gene, hic-1 |
05/23/1996 | CA2205392A1 Quantitative method for early detection of mutant alleles and diagnostic kits for carrying out the method |
05/23/1996 | CA2205377A1 Assay method for catheter related sepsis |
05/23/1996 | CA2205066A1 A partitioned microelectronic device array |
05/23/1996 | CA2205017A1 Method for the detection of ras oncogenes, in particular the k-ras oncogene |
05/23/1996 | CA2204914A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
05/23/1996 | CA2204908A1 Lipid cleavage enzyme |
05/23/1996 | CA2204871A1 Methods for modulating transcription from the amyloid .beta.-protein precursor (app) promoter |
05/23/1996 | CA2204849A1 Process for identifying para cation channel modulators |
05/23/1996 | CA2204744A1 Dna sequence and its use |
05/23/1996 | CA2204629A1 In vitro induction of dopaminergic cells |
05/23/1996 | CA2203654A1 Human stanniocalcin-alpha |
05/22/1996 | EP0713093A2 Improved methodology for colorimetrically determining the concentration of white blood cells in a biological fluid |
05/22/1996 | EP0713092A1 Method to detect factors in a model of paralysis and method to obtain this model |
05/22/1996 | EP0713087A1 Apparatus and process for rapid and ultrasensitive detection and counting of microorganisms by fluorescence |
05/22/1996 | EP0713086A1 Apparatus and process for the detection and counting of rarely occurring mammalian cells |
05/22/1996 | EP0712937A1 Method of determining chloride ion |
05/22/1996 | EP0712928A2 T cell antigen receptor |
05/22/1996 | EP0712444A1 In vivo nucleic acid hybridization method |
05/22/1996 | EP0712312A1 Suppression of inhibitors |
05/22/1996 | EP0712277A1 Jak kinases and regulation of cytokine signal transduction |
05/22/1996 | EP0532516B1 Substrate regenerating biosensor |
05/22/1996 | CN1122835A Method for detecting virus associated with hemorrhagic fever with renal syndrome |
05/21/1996 | US5519127 Nucleic acid probes for the detection of Pneumocystis carinii |
05/21/1996 | US5519120 Urokinase-type plasminogen activator receptor antibodies |
05/21/1996 | US5519118 Human MDM2 protein involved in human tumors |
05/21/1996 | US5519117 Polypeptide sequences as anticarcinogenic agents |
05/21/1996 | US5518928 Leukocyte differentiation method |
05/21/1996 | US5518901 Methods for adapting nucleic acid for detection, sequencing, and cloning using exonuclease |
05/21/1996 | US5518900 Method for generating single-stranded DNA molecules |
05/21/1996 | US5518894 Rapid coliform detection system |
05/21/1996 | US5518893 Aeration, culture with measurement of oxygen intake and calculation of oxygen demand |
05/21/1996 | US5518892 Apparatus and method for quantification of biological material in a liquid sample |
05/21/1996 | US5518891 Substituted anilines, hydrazones or 4-aminoantipyrines |
05/21/1996 | US5518886 Blood lead diagnostic assay |
05/21/1996 | US5518884 Hybridization probes, amplification primers |
05/21/1996 | US5518880 X-linked severe combined immunodeficiency diseases |
05/21/1996 | US5518723 Vaccines containing antibodies and epitopes |
05/21/1996 | CA2104413C Intrinsic factor - horse radish peroxidase conjugates |
05/21/1996 | CA2075824C Method and composition for determining antimicrobial susceptibility of the majority of clinically significant gram positive organisms |
05/17/1996 | WO1996014581A1 Method, reagent and kit for analysis of haemostatic activity |
05/17/1996 | WO1996014577A1 Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected |
05/17/1996 | WO1996014565A1 Method of testing immune competency |
05/17/1996 | WO1996014437A2 Detection of human retrovirus infection |
05/17/1996 | WO1996014435A1 USE OF NEURITE LOCALIZED mRNAs FOR MEDICAL DIAGNOSIS AND THERAPEUTICS |
05/17/1996 | WO1996014434A1 Method of dna sequencing |
05/17/1996 | WO1996014433A1 Process for determining the activity of specific phosphotyrosine phosphatases and specific effectors thereof in intact cells |
05/17/1996 | WO1996014432A2 Medium for detecting target microbes in a sample |
05/17/1996 | WO1996014431A1 Enzymatic method for detecting coliform bacteria or e. coli |
05/17/1996 | WO1996014430A1 A direct polymerase chain reaction assay, or bio-pcr |
05/17/1996 | WO1996014429A1 Container device and method for use in detecting microorganisms in a sample |
05/17/1996 | WO1996014411A1 Methods for the diagnosis of glaucoma |
05/17/1996 | WO1996014408A2 Nucleotide sequence encoding the enzyme i-scei and the uses thereof |
05/17/1996 | WO1996014406A1 Method of preparing oligonucleotide probes or primers, vector therefor and use thereof |
05/17/1996 | WO1996014403A1 A gene from the bacterium rhodothermus marinus, coding for the amino acid sequence of dna-ligase, produced in escherichia coli or some other suitable host organism |
05/17/1996 | WO1996014401A1 Transgenic organisms and their uses |
05/17/1996 | WO1996014334A1 IDENTIFICATION OF THE p21WAF1-PCNA INTERACTION SITE AND THERAPEUTIC APPLICATIONS THEREOF |
05/17/1996 | WO1996014328A1 Tumor necrosis factor-gamma |
05/17/1996 | WO1996014077A1 Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
05/17/1996 | WO1996014073A1 Treatment of urogenital cancer with boron neutron capture therapy |
05/17/1996 | WO1996014026A1 Analyte-controlled liquid delivery device and analyte monitor |
05/17/1996 | WO1996010639A3 The taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma |
05/17/1996 | WO1996008568A3 Cloning and expression of cdna for human dihydropyrimidine dehydrogenase |
05/17/1996 | CA2204637A1 Method of preparing oligonucleotide probes or primers, vector therefor and use thereof |
05/17/1996 | CA2204372A1 Detection of human retrovirus infection |
05/17/1996 | CA2204370A1 Analyte-controlled liquid delivery device and analyte monitor |
05/17/1996 | CA2203935A1 Transgenic organisms and their uses |
05/17/1996 | CA2203909A1 Identification of the p21waf1-pcna interaction site and therapeutic applications thereof |
05/17/1996 | CA2203651A1 Dna ligase iv |
05/17/1996 | CA2199943A1 Method of testing immune competency |
05/16/1996 | CA2161574A1 Methodology for colorimetrically determining the concentration of white blood cells in a biological fluid |
05/15/1996 | EP0711841A2 Nucléotide sequences hybridising specifically with a genomic sequence of Campylobacter coli |
05/15/1996 | EP0711840A2 DNA analyzing method and device therefor |
05/15/1996 | EP0711839A1 Calibrator for use in testing method to detect a defective clothing factor V |
05/15/1996 | EP0711838A1 Method to specifically detect an activated clothing factor V with an increased stability vis à vis activated protein C |